327056-71-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloro-5-cyano-benzoic acid is used as a key intermediate in the synthesis of pharmaceuticals for its ability to participate in a range of organic reactions. It contributes to the production of active pharmaceutical ingredients, facilitating the development of new drugs and medicines.
Used in Agrochemical Industry:
In the agrochemical sector, 3-chloro-5-cyano-benzoic acid serves as an intermediate in the creation of various agrochemicals. Its functional groups allow for the synthesis of compounds that can be used in pesticides, herbicides, and other agricultural chemicals to enhance crop protection and yield.
Used in Dye Industry:
3-Chloro-5-cyano-benzoic acid is utilized as a building block in the synthesis of dyes due to its capacity to form diverse organic compounds. Its involvement in dye production contributes to the creation of a wide array of colorants used in various industries, including textiles, plastics, and printing.
Used in Organic Synthesis:
Beyond its applications in specific industries, 3-chloro-5-cyano-benzoic acid is a significant chemical in organic synthesis. Its functional groups make it suitable for use in the creation of a broad spectrum of organic compounds, expanding its utility across the chemical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 327056-71-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,7,0,5 and 6 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 327056-71:
(8*3)+(7*2)+(6*7)+(5*0)+(4*5)+(3*6)+(2*7)+(1*1)=133
133 % 10 = 3
So 327056-71-3 is a valid CAS Registry Number.
327056-71-3Relevant academic research and scientific papers
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
-
, (2008/06/13)
The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
